StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.53−0.03 (-5.79%)

Close on Nov 18, 2026Market cap $1.36MP/E –Yield –

Calidi Biotherapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Calidi Biotherapeutics's revenue for the twelve months ending Dec 31, 2022 was $45.00K. For fiscal 2022 it was $45.00K.

Annual revenue

PeriodPeriod endValueChange
FY2022Dec 31, 2022$45.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$0–

More Calidi Biotherapeutics figures

See a number that looks wrong?